CN103797120B - 前列腺癌的生物学标志物、治疗靶点及其用途 - Google Patents
前列腺癌的生物学标志物、治疗靶点及其用途 Download PDFInfo
- Publication number
- CN103797120B CN103797120B CN201180073445.7A CN201180073445A CN103797120B CN 103797120 B CN103797120 B CN 103797120B CN 201180073445 A CN201180073445 A CN 201180073445A CN 103797120 B CN103797120 B CN 103797120B
- Authority
- CN
- China
- Prior art keywords
- gene
- prostate
- carcinoma
- fusion
- biological markers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (11)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510134173.7A CN104846070B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134199.1A CN104845992B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134100.8A CN104830972B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134196.8A CN104846072B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134198.7A CN104846073B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134175.6A CN104846071B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2011/079709 WO2013037118A1 (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
Related Child Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510134199.1A Division CN104845992B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134196.8A Division CN104846072B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134198.7A Division CN104846073B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134173.7A Division CN104846070B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134100.8A Division CN104830972B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
CN201510134175.6A Division CN104846071B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103797120A CN103797120A (zh) | 2014-05-14 |
CN103797120B true CN103797120B (zh) | 2017-04-12 |
Family
ID=47882537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180073445.7A Active CN103797120B (zh) | 2011-09-16 | 2011-09-16 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103797120B (zh) |
WO (1) | WO2013037118A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130079241A1 (en) | 2011-09-15 | 2013-03-28 | Jianhua Luo | Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse |
WO2015103057A1 (en) | 2013-12-30 | 2015-07-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fusion genes associated with progressive prostate cancer |
CN104805178A (zh) * | 2014-05-20 | 2015-07-29 | 吴松 | Tacc3-fgfr3融合基因序列、其检测方法以及其在检测膀胱癌中的应用 |
EP3193944B1 (en) | 2014-07-17 | 2021-04-07 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Methods of treating cells containing fusion genes |
JP6425942B2 (ja) * | 2014-08-20 | 2018-11-21 | 学校法人日本大学 | 前立腺癌の判定、治療選択方法、予防又は治療剤 |
CN104962654B (zh) * | 2014-11-18 | 2018-08-28 | 南京医科大学眼科医院 | lncRNA-MALAT1在制备增生性玻璃体视网膜病变诊断试剂中的应用 |
WO2016087430A1 (en) * | 2014-12-01 | 2016-06-09 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Novel RNA-biomarker signature for diagnosis of prostate cancer |
CN104611336B (zh) * | 2015-02-09 | 2017-06-23 | 上海长海医院 | 融合基因ttty15‑usp9y及其作为前列腺癌标志物的应用 |
EP3332037B1 (en) | 2015-08-07 | 2021-02-24 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Methods for predicting prostate cancer relapse |
CN105586399A (zh) * | 2015-09-07 | 2016-05-18 | 张国新 | 一种与胃癌相关的血清/血浆lncRNA标志物试剂盒 |
CN105925714A (zh) * | 2016-07-01 | 2016-09-07 | 北京泱深生物信息技术有限公司 | 一种诊断缺血性脑卒中的分子标志物 |
CN106967719B (zh) * | 2017-06-01 | 2021-04-13 | 上海长海医院 | 一种长链非编码rna作为前列腺癌分子标志物的应用 |
TWI793151B (zh) | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
SG11202011872QA (en) | 2018-07-10 | 2021-01-28 | Novartis Ag | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases |
AR116109A1 (es) | 2018-07-10 | 2021-03-31 | Novartis Ag | Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos |
CN109161598B (zh) * | 2018-11-29 | 2019-03-22 | 上海晟燃生物科技有限公司 | 前列腺癌早期诊断或预后评估标志物lncRNA malat1及其应用 |
CN112011610A (zh) * | 2019-05-30 | 2020-12-01 | 复旦大学附属肿瘤医院 | 一种用于癌症预后检测试剂盒 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101018874A (zh) * | 2004-08-13 | 2007-08-15 | 千年药品公司 | 用于鉴定、评估、预防和治疗前列腺癌的基因、组合物、试剂盒和方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004038076A1 (de) * | 2004-02-16 | 2005-09-01 | Proteosys Ag | Diagnostische Marker für Krebs |
GB0625321D0 (en) * | 2006-12-19 | 2007-01-24 | Univ Surrey | Cancer biomarker |
US8865400B2 (en) * | 2007-02-07 | 2014-10-21 | Decode Genetics Ehf. | Genetic variants contributing to risk of prostate cancer |
AU2009299862B2 (en) * | 2008-10-01 | 2016-02-04 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
-
2011
- 2011-09-16 WO PCT/CN2011/079709 patent/WO2013037118A1/zh active Application Filing
- 2011-09-16 CN CN201180073445.7A patent/CN103797120B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101018874A (zh) * | 2004-08-13 | 2007-08-15 | 千年药品公司 | 用于鉴定、评估、预防和治疗前列腺癌的基因、组合物、试剂盒和方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2013037118A1 (zh) | 2013-03-21 |
CN103797120A (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103797120B (zh) | 前列腺癌的生物学标志物、治疗靶点及其用途 | |
CN108753967B (zh) | 一种用于肝癌检测的基因集及其panel检测设计方法 | |
Farashi et al. | Post-GWAS in prostate cancer: from genetic association to biological contribution | |
Hennigan et al. | Low abundance of circulating tumor DNA in localized prostate cancer | |
Houlahan et al. | Genome-wide germline correlates of the epigenetic landscape of prostate cancer | |
Søreide et al. | Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist | |
CN102939389B (zh) | 基于体细胞获得性重排的诊断方法 | |
Gnanapragasam | Unlocking the molecular archive: the emerging use of formalin‐fixed paraffin‐embedded tissue for biomarker research in urological cancer | |
CN105779434A (zh) | 试剂盒及其用途 | |
US20190062841A1 (en) | Diagnostic assay for urine monitoring of bladder cancer | |
CN105779432A (zh) | 试剂盒及其用途 | |
Zhang et al. | Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis | |
CN104846070B (zh) | 前列腺癌的生物学标志物、治疗靶点及其用途 | |
CN116631508B (zh) | 肿瘤特异性突变状态的检测方法及其应用 | |
KR102203850B1 (ko) | 신경교종의 진단 또는 예후 예측용 조성물 및 이에 관한 정보를 제공하는 방법 | |
CN113544288A (zh) | 用于预测肝癌复发的dna甲基化标志物及其用途 | |
US10443102B2 (en) | Recurrent SPOP mutations in prostate cancer | |
CN108342483B (zh) | 一组用于非超突变型结直肠癌分子分型的基因及其应用 | |
CN110564851A (zh) | 一组用于非超突变型直肠癌分子分型的基因及其应用 | |
KR102325356B1 (ko) | 유사유전자를 이용한 신경교종의 악성도 진단용 조성물 및 이의 이용 | |
Badalamenti et al. | Cell-free/circulating tumor DNA profiling: from next-generation sequencing-based to digital polymerase chain reaction-based methods | |
CA3138719A1 (en) | Chromosome conformation markers of prostate cancer and lymphoma | |
WO2022107136A1 (en) | Methods and biomarkers for diagnostics, disease monitoring, personalized drug discovery and targeted therapy in glioma patients | |
KR20220071122A (ko) | 핵산 길이 비를 이용한 암 진단 및 예후예측 방법 | |
EP4185716A1 (en) | Method for in vitro diagnosis of head and neck cancer and related kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1192279 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151119 Address after: 200433 Shanghai city Yangpu District Changhai Road No. 168 Applicant after: Shanghai Changhai Hospital Applicant after: BGI SHENZHEN CO LTD Address before: 200433 Shanghai city Yangpu District Changhai Road No. 168 Applicant before: Shanghai Changhai Hospital Applicant before: BGI-Shenzhen Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1192279 Country of ref document: HK |